Lyell Immunopharma, Inc. (LYEL) › EPS (Basic)Lyell Immunopharma, Inc. (LYEL) — EPS (Basic)Annual figures by period end, from SEC filings.2019-12-31: $-24.042020-12-31: $-15.692021-12-31: $-1.842022-12-31: $-0.742023-12-31: $-18.702024-12-31: $-26.232025-12-31: $-16.06$-16.062019-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-16.06—2026-03-12From 2025-01-012024-12-31$-26.23—2026-03-12From 2024-01-012023-12-31$-18.70—2026-03-12From 2023-01-012022-12-31$-0.74—2025-03-11From 2022-01-012021-12-31$-1.84—2024-02-28From 2021-01-012020-12-31$-15.69—2023-02-28From 2020-01-012019-12-31$-24.04—2022-03-29From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares